BIOMAT Database Logo BIOMAT Database Logo

Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid. 1998

K Mdluli, and R A Slayden, and Y Zhu, and S Ramaswamy, and X Pan, and D Mead, and D D Crane, and J M Musser, and C E Barry
Tuberculosis Research Unit, Laboratory of Intracellular Parasites, Rocky Mountain Laboratories, National Institute for Allergy and Infectious Diseases (NIAID), National Institutes of Health, Hamilton, MT 59840, USA.

Although isoniazid (isonicotinic acid hydrazide, INH) is widely used for the treatment of tuberculosis, its molecular target has remained elusive. In response to INH treatment, saturated hexacosanoic acid (C26:0) accumulated on a 12-kilodalton acyl carrier protein (AcpM) that normally carried mycolic acid precursors as long as C50. A protein species purified from INH-treated Mycobacterium tuberculosis was shown to consist of a covalent complex of INH, AcpM, and a beta-ketoacyl acyl carrier protein synthase, KasA. Amino acid-altering mutations in the KasA protein were identified in INH-resistant patient isolates that lacked other mutations associated with resistance to this drug.

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D009171 Mycolic Acids Long fatty acids found in the CELL WALLS of some ACTINOBACTERIA, including MYCOBACTERIUM TUBERCULOSIS. Mycolic Acid,Acid, Mycolic,Acids, Mycolic
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005227 Fatty Acids Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (FATTY ACIDS, UNSATURATED). (Grant & Hackh's Chemical Dictionary, 5th ed) Aliphatic Acid,Esterified Fatty Acid,Fatty Acid,Fatty Acids, Esterified,Fatty Acids, Saturated,Saturated Fatty Acid,Aliphatic Acids,Acid, Aliphatic,Acid, Esterified Fatty,Acid, Saturated Fatty,Esterified Fatty Acids,Fatty Acid, Esterified,Fatty Acid, Saturated,Saturated Fatty Acids
D005798 Genes, Bacterial The functional hereditary units of BACTERIA. Bacterial Gene,Bacterial Genes,Gene, Bacterial

Related Publications

K Mdluli, and R A Slayden, and Y Zhu, and S Ramaswamy, and X Pan, and D Mead, and D D Crane, and J M Musser, and C E Barry
Modeling the interactions of herbal drugs to beta-ketoacyl ACP synthase of Mycobacterium tuberculosis H37Rv.
April 2008, Journal of biomolecular structure & dynamics,
K Mdluli, and R A Slayden, and Y Zhu, and S Ramaswamy, and X Pan, and D Mead, and D D Crane, and J M Musser, and C E Barry
In vitro inhibition of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein reductase MabA by isoniazid.
January 2004, Antimicrobial agents and chemotherapy,
K Mdluli, and R A Slayden, and Y Zhu, and S Ramaswamy, and X Pan, and D Mead, and D D Crane, and J M Musser, and C E Barry
The β-ketoacyl-ACP synthase from Mycobacterium tuberculosis as potential drug targets.
January 2011, Current medicinal chemistry,
K Mdluli, and R A Slayden, and Y Zhu, and S Ramaswamy, and X Pan, and D Mead, and D D Crane, and J M Musser, and C E Barry
Mycolic acid biosynthesis and enzymic characterization of the beta-ketoacyl-ACP synthase A-condensing enzyme from Mycobacterium tuberculosis.
June 2002, The Biochemical journal,
K Mdluli, and R A Slayden, and Y Zhu, and S Ramaswamy, and X Pan, and D Mead, and D D Crane, and J M Musser, and C E Barry
Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein (ACP) reductase: kinetic and chemical mechanisms.
October 2006, Biochemistry,
K Mdluli, and R A Slayden, and Y Zhu, and S Ramaswamy, and X Pan, and D Mead, and D D Crane, and J M Musser, and C E Barry
Identification of 2-aminothiazole-4-carboxylate derivatives active against Mycobacterium tuberculosis H37Rv and the beta-ketoacyl-ACP synthase mtFabH.
January 2009, PloS one,
K Mdluli, and R A Slayden, and Y Zhu, and S Ramaswamy, and X Pan, and D Mead, and D D Crane, and J M Musser, and C E Barry
Crystal structure of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III.
June 2001, The Journal of biological chemistry,
K Mdluli, and R A Slayden, and Y Zhu, and S Ramaswamy, and X Pan, and D Mead, and D D Crane, and J M Musser, and C E Barry
Acyl carrier protein (ACP) inhibition and other differences between beta-ketoacyl synthase (KAS) I and II.
December 2000, Biochemical Society transactions,
K Mdluli, and R A Slayden, and Y Zhu, and S Ramaswamy, and X Pan, and D Mead, and D D Crane, and J M Musser, and C E Barry
Mycobacterium tuberculosis beta-ketoacyl acyl carrier protein synthase III (mtFabH) assay: principles and method.
January 2008, Methods in molecular medicine,
K Mdluli, and R A Slayden, and Y Zhu, and S Ramaswamy, and X Pan, and D Mead, and D D Crane, and J M Musser, and C E Barry
Improved chemical and isotopic labeling of biomembranes in Bacillus subtilis by leveraging CRISPRi inhibition of beta-ketoacyl-ACP synthase (fabF).
January 2022, Frontiers in molecular biosciences,
Copied contents to your clipboard!